 Pseudomonas aeruginosa
"Pseudomonas aeruginosa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
| Descriptor ID |
D011550
|
| MeSH Number(s) |
B03.440.400.425.625.625.100 B03.660.250.580.590.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pseudomonas aeruginosa".
Below are MeSH descriptors whose meaning is more specific than "Pseudomonas aeruginosa".
This graph shows the total number of publications written about "Pseudomonas aeruginosa" by people in this website by year, and whether "Pseudomonas aeruginosa" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 2 | 4 | | 1997 | 3 | 2 | 5 | | 1998 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 3 | 0 | 3 | | 2002 | 9 | 0 | 9 | | 2003 | 2 | 1 | 3 | | 2004 | 11 | 3 | 14 | | 2005 | 1 | 4 | 5 | | 2006 | 7 | 0 | 7 | | 2007 | 6 | 2 | 8 | | 2008 | 3 | 3 | 6 | | 2009 | 6 | 5 | 11 | | 2010 | 5 | 1 | 6 | | 2011 | 5 | 4 | 9 | | 2012 | 6 | 4 | 10 | | 2013 | 13 | 2 | 15 | | 2014 | 17 | 6 | 23 | | 2015 | 6 | 6 | 12 | | 2016 | 5 | 4 | 9 | | 2017 | 3 | 3 | 6 | | 2018 | 1 | 6 | 7 | | 2019 | 13 | 6 | 19 | | 2020 | 5 | 6 | 11 | | 2021 | 7 | 4 | 11 | | 2022 | 5 | 4 | 9 | | 2023 | 1 | 5 | 6 | | 2024 | 4 | 2 | 6 | | 2025 | 0 | 3 | 3 | | 2026 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pseudomonas aeruginosa" by people in Profiles.
-
Penaranda C, Brenner EP, Clatworthy AE, Cosimi LA, Ravi J, Hung DT. Genomic comparison and phenotypic characterization of Pseudomonas aeruginosa isolates across environmental and diverse clinical isolation sites. mSystems. 2026 Mar 24; 11(3):e0136225.
-
Zang Z, Duncan OK, Sabonis D, Fedorova I, Shi Y, Miraj G, Le S, Deng J, Zhu Y, Cai Y, Zhang C, Arya G, Dixon SAH, Angus SP, Duerkop BA, Liang H, Pepin RH, Ve T, Bondy-Denomy J, Tamulaitiene G, Gerdt JP. Chemical inhibition of a bacterial immune system. Cell Host Microbe. 2026 Feb 11; 34(2):263-277.e11.
-
Weppner HK, Singh MA, Katsnelson EN, Douin DJ, McCarter MD, Tobin RP, Hind LE. Human M-MDSCs impair neutrophil migration in the infectious microenvironment. J Leukoc Biol. 2025 Dec 01; 117(12).
-
Tran SL, Lebreuilly L, Cormontagne D, Samson S, Tô TB, Stosskopf M, Dervyn R, Grießhammer A, de la Cuesta-Zuluaga J, Maier L, Naas T, Mura S, Rognan D, Nicolas J, André G, Ramarao N. An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens. Nat Commun. 2025 Apr 28; 16(1):3324.
-
Escobedo HD, Zawadzki N, Till JKA, Vazquez-Torres A, Wang G, Simberg D, Orlicky DJ, Johnson J, Guess MK, Nair DP, Schurr MJ. Nanogels conjugated with cell-penetrating peptide as drug delivery vehicle for treating urinary tract infections. Nanomedicine. 2025 04; 65:102812.
-
Pousty D, Ma B, Mathews C, Halanur M, Mamane H, Linden KG. Biofilm inactivation using LED systems emitting germicidal UV and antimicrobial blue light. Water Res. 2024 Dec 01; 267:122449.
-
Kandel SE, Tooker BC, Lampe JN. Drug metabolism of ciprofloxacin, ivacaftor, and raloxifene by Pseudomonas aeruginosa cytochrome P450 CYP107S1. J Biol Chem. 2024 08; 300(8):107594.
-
Calo CJ, Patil T, Palizzi M, Wheeler N, Hind LE. Collagen concentration regulates neutrophil extravasation and migration in response to infection in an endothelium dependent manner. Front Immunol. 2024; 15:1405364.
-
Mueller SW, Molina KC, Blass B, Gibson C, Kohler AD, Krsak M, Wiktor AJ. Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. J Burn Care Res. 2024 05 06; 45(3):808-810.
-
Neve RL, Giedraitis E, Akbari MS, Cohen S, Phelan VV. Secondary metabolite profiling of Pseudomonas aeruginosa isolates reveals rare genomic traits. mSystems. 2024 May 16; 9(5):e0033924.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|